MaxCyte
MaxCyte, Inc., a leading player in the cell engineering industry, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 1998, the company has established itself as a pioneer in the development of cell-based therapies and drug discovery solutions. MaxCyte's core offerings include its proprietary Flow Electroporation® technology, which enables the efficient delivery of nucleic acids into various cell types. This unique approach not only enhances the development of cell therapies but also accelerates the discovery of new drugs. With a strong market position, MaxCyte has achieved notable milestones, including partnerships with major pharmaceutical companies and biotechs, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
DitchCarbon Score
How does MaxCyte's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MaxCyte's score of 20 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MaxCyte's reported carbon emissions
MaxCyte, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, as indicated by the absence of specific figures. Additionally, there are no documented reduction targets or climate pledges outlined in their sustainability initiatives. As of now, MaxCyte has not cascaded any emissions data from a parent or related organization, meaning their climate commitments and performance metrics are independently reported. Without specific emissions data or reduction targets, it is challenging to assess their current climate impact or commitments within the industry context. MaxCyte's approach to sustainability and climate action remains unclear, and further information would be necessary to evaluate their environmental strategies effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MaxCyte is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
